Cochrane review supports change to COPD guidelines

In COPD, combining long-acting beta-agonists with long-acting muscarinics is better than long-acting beta-agonists with inhaled corticosteroids.
In COPD, combining long-acting beta-agonists with long-acting muscarinics is better than long-acting beta-agonists with inhaled corticosteroids.